These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 19700099)

  • 1. Update on PADI trial: percutaneous transluminal angioplasty and drug-eluting stents for infrapopliteal lesions in critical limb ischemia.
    Martens JM; Knippenberg B; Vos JA; de Vries JP; Hansen BE; van Overhagen H;
    J Vasc Surg; 2009 Sep; 50(3):687-9. PubMed ID: 19700099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invited commentary.
    Forbes TL
    J Vasc Surg; 2009 Sep; 50(3):690. PubMed ID: 19700100
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-Term Follow-up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia.
    Spreen MI; Martens JM; Knippenberg B; van Dijk LC; de Vries JPM; Vos JA; de Borst GJ; Vonken EPA; Bijlstra OD; Wever JJ; Statius van Eps RG; Mali WPTM; van Overhagen H
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary: infrapopliteal angioplasty with drug-eluting stents: from heart to toe.
    Siablis D; Katsanos K; Karnabatidis D
    J Endovasc Ther; 2010 Aug; 17(4):488-91. PubMed ID: 20681764
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia.
    Karnabatidis D; Spiliopoulos S; Diamantopoulos A; Katsanos K; Kagadis GC; Kakkos S; Siablis D
    J Endovasc Ther; 2011 Feb; 18(1):1-12. PubMed ID: 21314342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infrapopliteal stents: overview and unresolved issues.
    Karnabatidis D; Katsanos K; Siablis D
    J Endovasc Ther; 2009 Feb; 16 Suppl 1():I153-62. PubMed ID: 19317574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial.
    Zeller T; Baumgartner I; Scheinert D; Brodmann M; Bosiers M; Micari A; Peeters P; Vermassen F; Landini M; Snead DB; Kent KC; Rocha-Singh KJ;
    J Am Coll Cardiol; 2014 Oct; 64(15):1568-76. PubMed ID: 25301459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recalcitrant in-stent restenosis of the celiac trunk treated by drug-eluting stent.
    Visconti G; Taranto D; Briguori C
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):873-6. PubMed ID: 19009632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia.
    Liistro F; Porto I; Angioli P; Grotti S; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    Circulation; 2013 Aug; 128(6):615-21. PubMed ID: 23797811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous interventions below the knee in patients with critical limb ischemia using drug eluting stents.
    Balzer JO; Zeller T; Rastan A; Sixt S; Vogl TJ; Lehnert T; Khan V
    J Cardiovasc Surg (Torino); 2010 Apr; 51(2):183-91. PubMed ID: 20354488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease.
    Bosiers M; Scheinert D; Peeters P; Torsello G; Zeller T; Deloose K; Schmidt A; Tessarek J; Vinck E; Schwartz LB
    J Vasc Surg; 2012 Feb; 55(2):390-8. PubMed ID: 22169682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
    Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial.
    Zeller T; Baumgartner I; Scheinert D; Brodmann M; Bosiers M; Micari A; Peeters P; Vermassen F; Landini M;
    Trials; 2014 Feb; 15():63. PubMed ID: 24552184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial.
    Rastan A; Tepe G; Krankenberg H; Zahorsky R; Beschorner U; Noory E; Sixt S; Schwarz T; Brechtel K; Böhme C; Neumann FJ; Zeller T
    Eur Heart J; 2011 Sep; 32(18):2274-81. PubMed ID: 21622669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefit.
    Siablis D; Karnabatidis D; Katsanos K; Kagadis GC; Kraniotis P; Diamantopoulos A; Tsolakis J
    J Endovasc Ther; 2007 Apr; 14(2):241-50. PubMed ID: 17484536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary use of sirolimus-eluting stents in the infrapopliteal arteries.
    Rastan A; Schwarzwälder U; Noory E; Taieb FH; Beschorner U; Sixt S; Bürgelin K; Amantea P; Neumann FJ; Zeller T
    J Endovasc Ther; 2010 Aug; 17(4):480-7. PubMed ID: 20681763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-eluting stents for treatment of focal infrapopliteal lesions.
    Rastan A; Noory E; Zeller T
    Vasa; 2012 Mar; 41(2):90-5. PubMed ID: 22403126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infrapopliteal drug-eluting stents for chronic limb ischemia.
    Grant AG; White CJ; Collins TJ; Jenkins JS; Reilly JP; Ramee SR
    Catheter Cardiovasc Interv; 2008 Jan; 71(1):108-11. PubMed ID: 18098211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.